《European Journal of Nuclear Medicine and Molecular Imaging,2月14日,Imaging features of 2019 novel coronavirus pneumonia》

  • 来源专题:COVID-19科研动态监测
  • 编译者: dingxq
  • 发布时间:2020-02-16
  • Imaging features of 2019 novel coronavirus pneumonia

    Xi Xu, Chengcheng Yu, Lieguang Zhang, Liangping Luo & Jinxin Liu

    DOI:https://doi.org/10.1007/s00259-020-04720-2

    Recently, a type of pneumonia caused by a novel Betacoronavirus, the 2019 novel coronavirus (2019-nCoV), has spread in China, mainly in Wuhan [1]. It is known that cases of this disease have also been identified in other provinces of China [2].

    A 53-year-old man has lived in Wuhan for many years, and recently came to Guangzhou, China. He was admitted to the hospital with fever and cough in the last 2 days, and his highest body temperature was 38.3 °C before admission. The laboratory examinations showed decreased white blood cell count (2.50 × 109/L) and elevated C-reactive protein (16.2 mg/L; normal range 0–10 mg/L).

    Non-contrast-enhanced chest computed tomography (CT) (Fig. 1a, b) showed multiple, bilateral, peripheral, patchy ground glass opacities, lobular, and subsegmental, with fading margins. The lesions had mainly a subpleural distribution.

    CT also demonstrated slight thickening of the adjacent pleura (yellow arrow) and interlobular septa in the lesion (red arrow). Subsequently, the patients had laboratory-confirmed 2019-nCoV infection by real-time polymerase chain reaction (PCR). After 5 days, CT scan (Fig. 1c, d) showed enlarged lesions, compared with previous images, and progressive ground glass opacities in both lower lobes, indicating disease progression.

    Infection with 2019-nCoV was confirmed based on the patient’s epidemiological history, clinical manifestations, imaging characteristics, and laboratory tests.

    Bilateral, multiple, patchy, or ground glass opacities, with subpleural distribution, were the lung CT appearances of this patient, affected by 2019-nCoV pneumonia. These characteristics should be recognized by professionals working in imaging departments.

  • 原文来源:https://link.springer.com/article/10.1007%2Fs00259-020-04720-2
相关报告
  • 《EJNMMI,2月28日,Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-01
    • Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 Xi Xu, Chengcheng Yu, Jing Qu, Lieguang Zhang, Songfeng Jiang, Deyang Huang, Bihua Chen, Zhiping Zhang, Wanhua Guan, Zhoukun Ling, Rui Jiang, Tianli Hu, Yan Ding, Lin Lin, Qingxin Gan, Liangping Luo, Xiaoping Tang & Jinxin Liu European Journal of Nuclear Medicine and Molecular Imaging (2020) Abstract Background The pneumonia caused by the 2019 novel coronavirus (SARS-CoV-2, also called 2019-nCoV) recently break out in Wuhan, China, and was named as COVID-19. With the spread of the disease, similar cases have also been confirmed in other regions of China. We aimed to report the imaging and clinical characteristics of these patients infected with SARS-CoV-2 in Guangzhou, China.
  • 《SSRN,2月28日,Key Points of Clinical and CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Imported Pneumonia Based on 21 Cases Analysis》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-29
    • Key Points of Clinical and CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Imported Pneumonia Based on 21 Cases Analysis 19 Pages Posted: 28 Feb 2020 Zhifeng Xu Government of the People's Republic of China - Department of Radiology Wenxiu Wu Government of the People's Republic of China - Department of Radiology Abstract Background and Objective: WHO Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern,and the outbreak is still on-going.Chest CT had been a key component of the diagnostic workup for patients with suspected infection. In this retrospective study, we attempt to summarize and analyze the chest CT features of 2019-nCov infections, and to identify the typical features to improved the diagnostic accuracy of new coronavirus pneumonia (NCP).